North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on June 30, 2026

Jun. 30, 2026

TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey

Indeterminate GlobeNewswire

Jun. 30, 2026

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

Indeterminate GlobeNewswire

Jun. 30, 2026

Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial

Indeterminate GlobeNewswire

Jun. 30, 2026

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Indeterminate GlobeNewswire

Jun. 30, 2026

Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

Indeterminate GlobeNewswire

Jun. 30, 2026

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

Jun. 30, 2026

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Indeterminate GlobeNewswire

Jun. 30, 2026

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Indeterminate GlobeNewswire

Jun. 30, 2026

Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections

Indeterminate GlobeNewswire

Jun. 30, 2026

Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA

Indeterminate GlobeNewswire

Jun. 30, 2026

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Indeterminate GlobeNewswire

Jun. 30, 2026

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

Indeterminate GlobeNewswire

Jun. 30, 2026

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

Beeline Medicines Announces Upsized Series A of $426.3 Million to Advance Category-Leading Autoimmune and Inflammatory Disease Portfolio

Indeterminate GlobeNewswire

Jun. 30, 2026

Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

Indeterminate GlobeNewswire

Jun. 30, 2026

Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development

Indeterminate GlobeNewswire

Jun. 30, 2026

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

Indeterminate GlobeNewswire

Jun. 30, 2026

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Indeterminate GlobeNewswire

Jun. 30, 2026

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Indeterminate GlobeNewswire